Does muscle-derived interleukin-6 mediate some of the beneficial effects of exercise on cancer treatment-related fatigue

Lisa Wood, Lillian Nail, Kerri Winters-Stone

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Purpose/Objectives: To review evidence that musclederived interleukin-6 (IL-6) mediates some of the beneficial effects of exercise on cancer treatment-related fatigue (CTRF). Data Sources: Electronic nursing, psychology, and medicine databases. Data Synthesis: Fatigue is a common and often debilitating symptom associated with cancer treatment. Although the molecular mechanisms underlying CTRF have yet to be fully elucidated, it may be akin to the fatigue associated with "sickness behavior," which is initiated by the production of the proinflammatory cytokines interleukin-1 beta (IL-1ß) and tumor necrosis factor alpha (TNF-a). Physical exercise has been shown to decrease fatigue levels in patients with cancer undergoing treatment. Skeletal muscle selectively produces IL-6 during exercise, and muscle-derived IL-6 can decrease the production and activity of IL-1b and TNF-a. Thus, the anti-inflammatory effects of muscle-derived IL-6 may be a mechanism underlying the observed beneficial effects of exercise on CTRF. Conclusions: Further studies are needed to determine whether the anti-inflammatory effects of exercise underlie its beneficial effects on CTRF. Implications for Nursing: Nurses have proven to be leaders in the field of cancer symptom management. An understanding of potential mechanisms underlying the beneficial effects of exercise on CTRF may help to fine-tune exercise interventions to maximize symptom control and to identify new treatment strategies for fatigued patients with cancer who are unable to participate in an exercise program.

Original languageEnglish (US)
Pages (from-to)519-524
Number of pages6
JournalOncology Nursing Forum
Volume36
Issue number5
DOIs
StatePublished - Sep 2009

Fingerprint

Second Primary Neoplasms
Fatigue
Interleukin-6
Exercise
Muscles
Nursing
Anti-Inflammatory Agents
Tumor Necrosis Factor-alpha
Illness Behavior
Neoplasms
Information Storage and Retrieval
Interleukin-1beta
Skeletal Muscle
Nurses
Medicine
Databases
Cytokines
Psychology
Therapeutics

ASJC Scopus subject areas

  • Oncology(nursing)

Cite this

Does muscle-derived interleukin-6 mediate some of the beneficial effects of exercise on cancer treatment-related fatigue. / Wood, Lisa; Nail, Lillian; Winters-Stone, Kerri.

In: Oncology Nursing Forum, Vol. 36, No. 5, 09.2009, p. 519-524.

Research output: Contribution to journalArticle

@article{7f9b662de27c4cb19e5441c1ccb73d46,
title = "Does muscle-derived interleukin-6 mediate some of the beneficial effects of exercise on cancer treatment-related fatigue",
abstract = "Purpose/Objectives: To review evidence that musclederived interleukin-6 (IL-6) mediates some of the beneficial effects of exercise on cancer treatment-related fatigue (CTRF). Data Sources: Electronic nursing, psychology, and medicine databases. Data Synthesis: Fatigue is a common and often debilitating symptom associated with cancer treatment. Although the molecular mechanisms underlying CTRF have yet to be fully elucidated, it may be akin to the fatigue associated with {"}sickness behavior,{"} which is initiated by the production of the proinflammatory cytokines interleukin-1 beta (IL-1{\ss}) and tumor necrosis factor alpha (TNF-a). Physical exercise has been shown to decrease fatigue levels in patients with cancer undergoing treatment. Skeletal muscle selectively produces IL-6 during exercise, and muscle-derived IL-6 can decrease the production and activity of IL-1b and TNF-a. Thus, the anti-inflammatory effects of muscle-derived IL-6 may be a mechanism underlying the observed beneficial effects of exercise on CTRF. Conclusions: Further studies are needed to determine whether the anti-inflammatory effects of exercise underlie its beneficial effects on CTRF. Implications for Nursing: Nurses have proven to be leaders in the field of cancer symptom management. An understanding of potential mechanisms underlying the beneficial effects of exercise on CTRF may help to fine-tune exercise interventions to maximize symptom control and to identify new treatment strategies for fatigued patients with cancer who are unable to participate in an exercise program.",
author = "Lisa Wood and Lillian Nail and Kerri Winters-Stone",
year = "2009",
month = "9",
doi = "10.1188/09.ONF.519-524",
language = "English (US)",
volume = "36",
pages = "519--524",
journal = "Oncology Nursing Forum",
issn = "0190-535X",
publisher = "Oncology Nursing Society",
number = "5",

}

TY - JOUR

T1 - Does muscle-derived interleukin-6 mediate some of the beneficial effects of exercise on cancer treatment-related fatigue

AU - Wood, Lisa

AU - Nail, Lillian

AU - Winters-Stone, Kerri

PY - 2009/9

Y1 - 2009/9

N2 - Purpose/Objectives: To review evidence that musclederived interleukin-6 (IL-6) mediates some of the beneficial effects of exercise on cancer treatment-related fatigue (CTRF). Data Sources: Electronic nursing, psychology, and medicine databases. Data Synthesis: Fatigue is a common and often debilitating symptom associated with cancer treatment. Although the molecular mechanisms underlying CTRF have yet to be fully elucidated, it may be akin to the fatigue associated with "sickness behavior," which is initiated by the production of the proinflammatory cytokines interleukin-1 beta (IL-1ß) and tumor necrosis factor alpha (TNF-a). Physical exercise has been shown to decrease fatigue levels in patients with cancer undergoing treatment. Skeletal muscle selectively produces IL-6 during exercise, and muscle-derived IL-6 can decrease the production and activity of IL-1b and TNF-a. Thus, the anti-inflammatory effects of muscle-derived IL-6 may be a mechanism underlying the observed beneficial effects of exercise on CTRF. Conclusions: Further studies are needed to determine whether the anti-inflammatory effects of exercise underlie its beneficial effects on CTRF. Implications for Nursing: Nurses have proven to be leaders in the field of cancer symptom management. An understanding of potential mechanisms underlying the beneficial effects of exercise on CTRF may help to fine-tune exercise interventions to maximize symptom control and to identify new treatment strategies for fatigued patients with cancer who are unable to participate in an exercise program.

AB - Purpose/Objectives: To review evidence that musclederived interleukin-6 (IL-6) mediates some of the beneficial effects of exercise on cancer treatment-related fatigue (CTRF). Data Sources: Electronic nursing, psychology, and medicine databases. Data Synthesis: Fatigue is a common and often debilitating symptom associated with cancer treatment. Although the molecular mechanisms underlying CTRF have yet to be fully elucidated, it may be akin to the fatigue associated with "sickness behavior," which is initiated by the production of the proinflammatory cytokines interleukin-1 beta (IL-1ß) and tumor necrosis factor alpha (TNF-a). Physical exercise has been shown to decrease fatigue levels in patients with cancer undergoing treatment. Skeletal muscle selectively produces IL-6 during exercise, and muscle-derived IL-6 can decrease the production and activity of IL-1b and TNF-a. Thus, the anti-inflammatory effects of muscle-derived IL-6 may be a mechanism underlying the observed beneficial effects of exercise on CTRF. Conclusions: Further studies are needed to determine whether the anti-inflammatory effects of exercise underlie its beneficial effects on CTRF. Implications for Nursing: Nurses have proven to be leaders in the field of cancer symptom management. An understanding of potential mechanisms underlying the beneficial effects of exercise on CTRF may help to fine-tune exercise interventions to maximize symptom control and to identify new treatment strategies for fatigued patients with cancer who are unable to participate in an exercise program.

UR - http://www.scopus.com/inward/record.url?scp=77949320723&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77949320723&partnerID=8YFLogxK

U2 - 10.1188/09.ONF.519-524

DO - 10.1188/09.ONF.519-524

M3 - Article

C2 - 19726392

AN - SCOPUS:77949320723

VL - 36

SP - 519

EP - 524

JO - Oncology Nursing Forum

JF - Oncology Nursing Forum

SN - 0190-535X

IS - 5

ER -